Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Holdings Lifted by NewSquare Capital LLC

NewSquare Capital LLC increased its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 3.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 47,948 shares of the company’s stock after purchasing an additional 1,445 shares during the quarter. NewSquare Capital LLC’s holdings in Acadia Healthcare were worth $3,728,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. GAMMA Investing LLC bought a new position in shares of Acadia Healthcare during the 4th quarter worth about $26,000. Jennison Associates LLC raised its holdings in Acadia Healthcare by 26.1% in the 4th quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock valued at $89,327,000 after acquiring an additional 238,114 shares in the last quarter. Handelsbanken Fonder AB grew its holdings in shares of Acadia Healthcare by 9.8% during the 4th quarter. Handelsbanken Fonder AB now owns 15,674 shares of the company’s stock worth $1,219,000 after purchasing an additional 1,400 shares in the last quarter. abrdn plc acquired a new position in shares of Acadia Healthcare in the fourth quarter valued at $7,847,000. Finally, Tranquility Partners LLC boosted its stake in Acadia Healthcare by 5.3% during the fourth quarter. Tranquility Partners LLC now owns 3,395 shares of the company’s stock worth $264,000 after buying an additional 170 shares in the last quarter.

Acadia Healthcare Trading Up 0.6 %

ACHC traded up $0.39 during midday trading on Wednesday, reaching $71.13. 206,917 shares of the company were exchanged, compared to its average volume of 557,110. Acadia Healthcare Company, Inc. has a one year low of $66.49 and a one year high of $87.77. The stock’s 50-day simple moving average is $78.68 and its 200 day simple moving average is $77.72. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.67 and a quick ratio of 0.67.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.05. The business had revenue of $742.80 million for the quarter, compared to analyst estimates of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. Acadia Healthcare’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.70 EPS. As a group, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current year.

Insider Activity

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now directly owns 46,074 shares in the company, valued at $3,934,258.86. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 2.80% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Mizuho increased their target price on Acadia Healthcare from $77.00 to $84.00 and gave the stock a “neutral” rating in a report on Wednesday, March 6th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a report on Monday, March 4th. UBS Group raised their price objective on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Stephens raised shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target on the stock in a research note on Friday, January 5th. Finally, TD Cowen boosted their price objective on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.75.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.